Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BAT followed by enzalutamide or abiraterone in prostate cancer
NCT02090114Phase 2Completed
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- Aug 2014
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of testosterone cypionate in prostate cancer (PCa), sponsored by Sidney Kimmel Comprehensive Cancer Center. Started Aug 2014; status: completed.
02
Drugs
testosterone cypionate
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT02090114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02090114.